Rituximab with interleukin-2 after autologous bone marrow transplantation for acute lymphocytic leukemia in second remission
Published inMedical and pediatric oncology, vol. 38, no. 4, p. 300-301
Publication date2002
Keywords
- Adjuvants, Immunologic/administration & dosage
- Adolescent
- Antibodies, Monoclonal/administration & dosage
- Antibodies, Monoclonal, Murine-Derived
- Antineoplastic Agents/administration & dosage
- Bone Marrow Transplantation
- Female
- Humans
- Interleukin-2/administration & dosage
- Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy/therapy
- Recurrence
- Remission Induction
- Transplantation, Autologous
Citation (ISO format)
OZSAHIN, Ayse Hulya et al. Rituximab with interleukin-2 after autologous bone marrow transplantation for acute lymphocytic leukemia in second remission. In: Medical and pediatric oncology, 2002, vol. 38, n° 4, p. 300–301. doi: 10.1002/mpo.1335
Main files (1)
Article (Published version)
Identifiers
- PID : unige:55974
- DOI : 10.1002/mpo.1335
- PMID : 11920807
Journal ISSN0098-1532
